Kiadis Pharma
Amsterdam
About Kiadis Pharma
Kiadis Pharma is a biopharmaceutical company focused on complications and limitations of hematopoietic stem cell transplants in blood cancer patients. The company has three blood cancer products in clinical development that offer novel treatment options for terminally ill cancer patients addressing high-unmet medical needs. Kiadis Pharma is headquartered in Amsterdam, The Netherlands.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Public
- Employees: 101 – 250
- Estimated revenue: $10K – $50K
- Total funding: $88.9M
- Funding stage: M&A
- Last round: Post-IPO Equity (Sep 2020)
- Ticker: ams:KDS
- Website: kiadis.com
- Phone: +31 20 314 0250
Industries & Categories
Biopharma, Biotechnology, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/kiadis-pharma-183643 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.